Head-to-head · Cost-Efficiency Index
Heros Health vs Mojoon
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Heros Health
Cost-first shoppers who want compounded GLP-1s with a 90-day money-back guarantee.
Visit Heros HealthMojoon
Shoppers comfortable reading past a marketing headline to a lower published starting-dose price.
Visit MojoonThe verdict
Heros Health and Mojoon tie on the Cost-Efficiency Index at 53/100, so neither wins outright on the numbers. For most shoppers we'd start with Heros Health (ranked #373, a hair above #377) — Cost-first shoppers who want compounded GLP-1s with a 90-day money-back guarantee. But Mojoon is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Heros Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Heros Health | Mojoon |
|---|---|---|
| Cost-Efficiency Index | 53/100 | 53/100 |
| Semaglutide / mo | $199/mo (compounded) | $350/mo (0.25 mg dose, compounded) |
| Tirzepatide / mo | $199/mo (compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $2,388 | $4,200 |
| Tirzepatide / yr (modeled) | $2,388 | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #373 | #377 |
Heros Health
53/100Where the value is
- Compounded semaglutide and tirzepatide on a flat program price, not tiered by dose
- Transparent pricing: $149 first month, then $199/mo (or $165/mo on the 3-month plan)
- 90-day money-back guarantee on GLP-1 treatment
The tradeoffs
- Compounded GLP-1s are not FDA-approved finished products
- Specific 503A pharmacy partner is not named publicly
Mojoon
53/100Where the value is
- Publishes an actual price range ($350-$520/treatment) rather than a single vague 'starting at' figure, and explains why the price rises (monthly dose escalation from 0.25 mg to 2.4 mg)
- Claims LegitScript certification, and pharmacy licensure across all 50 states for dispensing even though provider coverage is 48 states
- No long-term contract or hidden fees claimed on the product page
The tradeoffs
- The site's own prominent marketing figure ('$450 per month') is HIGHER than its own disclosed starting-dose floor ($350) — the headline number is not the entry price
- Tirzepatide is listed as an offered treatment in the navigation but its dedicated page carries no pricing at all
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.